10:56 AM EST - Chemokine Therapeutics Corp. : incurred a net loss of $751,931 or 2 cents per share for the three months ended March 31, 2008, that compared to $1,611,937 or 4 cents per share for the three months ended March 31, 2007. Chemokine Therapeutics Corp.
shares T.CTI are trading unchanged at $0.14.